1 result(s) displayed (1 - 1 of 1):
Strategic alliances have always been an efficient mechanism for pharmaceutical companies to pursue development of multiple drugs. But as R&D costs skyrocket and the length of time required for regulatory approval lengthens, they're becoming an even more critical tool. On Wednesday, GlaxoSmithKline plc and Pfizer Inc. both announced new R&D partnerships....
Posted on December 18, 2008 10:18 AM
Movable Type search results powered by Fast Search